Test drug 2
Sponsors
Chong Kun Dang Pharmaceutical
Conditions
Cardiovascular Diseases
Phase 1
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
CompletedNCT04083846
Start: 2019-09-06End: 2019-10-25Updated: 2020-02-05
Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions
NCT04651881
Start: 2020-10-27End: 2020-12-09Updated: 2020-12-03
Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions
NCT04678388
Start: 2020-10-29End: 2020-12-12Target: 24Updated: 2020-12-21